- Trials with a EudraCT protocol (43)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
43 result(s) found for: Uterine cavity.
Displaying page 1 of 3.
EudraCT Number: 2014-000964-16 | Sponsor Protocol Number: 1311-BCN-138-DG | Start Date*: 2015-03-30 |
Sponsor Name:IVI Valencia | ||
Full Title: Uterine fibroids: Impact of ulipristal acetate 10 mg on ART results. | ||
Medical condition: Uterine Fibroids and Assisted Reproduction | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002051-13 | Sponsor Protocol Number: PANN3006 | Start Date*: 2005-08-17 |
Sponsor Name:Imperial College, London | ||
Full Title: A randomised double-blind placebo-controlled trial of oral misoprostol for cervical priming before outpatient hysteroscopy | ||
Medical condition: Abnormal uterine bleeding (hysteroscopy to investigate and treatment of abnormal uterine bleeding) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2018-002897-27 | Sponsor Protocol Number: 18E-Prg06 | Start Date*: 2018-12-21 | |||||||||||
Sponsor Name:IBSA, Institut Biochimique, S.A. | |||||||||||||
Full Title: A proof of concept, randomized, controlled clinical trial to assess the efficacy of subcutaneous progesterone (Prolutex) versus vaginal proges-terone (Progeffik) for endometrial preparation in wome... | |||||||||||||
Medical condition: Infertility. Assisted Reproductive Tecniques. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001256-22 | Sponsor Protocol Number: GL0817-01 | Start Date*: 2017-01-31 | |||||||||||
Sponsor Name:Gliknik Inc | |||||||||||||
Full Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of GL-0817 (with Cyclophosphamide) for the Prevention of Recurrence in HLA-A2+ Patients wi... | |||||||||||||
Medical condition: Prevention of Recurrence in HLA-A2+ Patients with High-Risk Squamous Cell Carcinoma of the Oral Cavity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Prematurely Ended) PL (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001182-21 | Sponsor Protocol Number: APC-01-2021 | Start Date*: 2021-06-21 | |||||||||||
Sponsor Name:University Hospital Puerta de Hierro Majadahonda, Madrid, Spain | |||||||||||||
Full Title: RANDOMIZED, UNICENTRIC, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE EFFICACY OF PARACERVICAL ANESTHESIA FOR PAIN CONTROL DURING AN OFFICE HYSTEROSCOPY | |||||||||||||
Medical condition: Need to do an office Hysteroscopy for any reason | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002254-40 | Sponsor Protocol Number: 14-OBE001-013 | Start Date*: 2014-09-22 | |||||||||||
Sponsor Name:ObsEva SA | |||||||||||||
Full Title: A phase 2, double-blind, dose-finding, placebo-controlled study to assess the safety and efficacy of a single oral administration of OBE001 to improve embryo implantation following IVF or ICSI. | |||||||||||||
Medical condition: Embryo implantation in women undergoing embyo transfer following IVF/ICSI in the context of Assisted Reproductive Technology (ART). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) DK (Completed) CZ (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001014-15 | Sponsor Protocol Number: S61372 | Start Date*: 2018-06-26 |
Sponsor Name:university hospital leuven | ||
Full Title: Frozen-thawed embryo transfer in a natural versus artificial cycle: a randomized clinical trial | ||
Medical condition: Patients with subfertility having frozen embryos after in vitro fertilization (IVF) or intracytoplasmatic sperm injection (ICSI) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007661-20 | Sponsor Protocol Number: 1 | Start Date*: 2008-04-21 | |||||||||||
Sponsor Name:Lil Valentin, Region Skåne, Malmö University Hospital, Dpt Obstetrics and Gynecology [...] | |||||||||||||
Full Title: Which is the optimal treatment for miscarriage with a gestational sac in the uterus and which factors can predict if the treatment will be successful? | |||||||||||||
Medical condition: Miscarriage before 14 gestational weeks with a gestational sac in the uterus identified at ultrasound examiantion | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023867-17 | Sponsor Protocol Number: S52775 | Start Date*: 2011-03-25 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Impact of luteal phase support with vaginal progesterone on the clinical pregnancy rate in IUI cycles stimulated with gonadotrophins: a prospective randomized multicentre study. | ||||||||||||||||||
Medical condition: Subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000689-13 | Sponsor Protocol Number: HRT1vs2week.2018 | Start Date*: 2018-07-11 | |||||||||||
Sponsor Name:University hospital Brussel | |||||||||||||
Full Title: Clinical pregnancy rate for frozen embryo transfer with HRT: a pilot study comparing 1 versus 2 weeks of treatment | |||||||||||||
Medical condition: Subfertility in need of IVF and IVF-ICSI treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003645-16 | Sponsor Protocol Number: 2019_0012 | Start Date*: 2020-02-25 |
Sponsor Name:Hopital Foch | ||
Full Title: Benefit of the GnRH agonist before frozen embryo transfer in patients with endometriosis and / or adenomyosis: randomized prospective study | ||
Medical condition: Frozen embryo transfer in patients with endometriosis and/or adenomyosis | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004592-40 | Sponsor Protocol Number: 1 | Start Date*: 2020-11-20 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: An open label exploratory study to assess the safety of using 100mg of methotrexate as a standard dose treatment for women with unruptured tubal ectopic pregnancy (OSPREY) | |||||||||||||
Medical condition: Ectopic Pregnancy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019287-37 | Sponsor Protocol Number: FIN3001 | Start Date*: 2010-08-24 |
Sponsor Name:Finox AG | ||
Full Title: A phase III assessor-blinded randomised parallel group multi-centre study to compare efficacy adn safety of two r-hFSH formulations (AFOLIA and Gonal-f®) in women for assisted reproductive treatment | ||
Medical condition: Stimulation of multifollicular develoment in patients undergoing assisted reproductivet treatment | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) AT (Completed) ES (Completed) GB (Prematurely Ended) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005420-42 | Sponsor Protocol Number: S55983 | Start Date*: 2014-02-06 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Is postoperative IUI better than expectant management in infertile endometriosis patients with good prognosis based on EFI score? | ||||||||||||||||||
Medical condition: (Sub)Fertility in endometriosis after laparoscopic removal of the endometriosos lesions: an RCT comparing intra-uterine insemination with expectant management | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001731-55 | Sponsor Protocol Number: 106636 | Start Date*: 2007-08-09 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A phase III/IV, community-randomized, controlled study to evaluate the effectiveness of two vaccination strategies using GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine in reducing the p... | |||||||||||||
Medical condition: For the prevention of high-grade cervical intraepithelial neoplasia (CIN grades 2 and 3) and cervical cancer causally related to human papillomavirus (HPV) types 16 and 18. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004445-26 | Sponsor Protocol Number: A65870 | Start Date*: 2015-03-27 | |||||||||||
Sponsor Name:World Health Organization | |||||||||||||
Full Title: A phase III, randomized, double-blind, active, controlled, multinational, multicentre, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorr... | |||||||||||||
Medical condition: Postpartum haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003080-30 | Sponsor Protocol Number: CT2011-001 | Start Date*: 2011-07-26 | |||||||||||
Sponsor Name:ISTITUTO CLINICO HUMANITAS | |||||||||||||
Full Title: WEIGHT-ADJUSTED LOW MOLECOLAR WEIGHT HEPARIN IN RECURRENT IMPLANTATION FAILURE: A RANDOMIZED OPEN LABELED TRIAL | |||||||||||||
Medical condition: Infertile patients with at least three failed assisted reproductive tecniques | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006595-11 | Sponsor Protocol Number: 07EU/Prg06 | Start Date*: 2008-09-25 | |||||||||||
Sponsor Name:IBSA Institut Biochimique SA | |||||||||||||
Full Title: Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF). | |||||||||||||
Medical condition: Patient undergoing in-Vitro Fertilization (IVF) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000993-32 | Sponsor Protocol Number: S55300 | Start Date*: 2013-05-07 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Does prolonged GnRH downregulation prior to ART improve the clinical pregnancy rate in postoperative endometriosis patients? A RCT | ||||||||||||||||||
Medical condition: endometriosis, subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000335-28 | Sponsor Protocol Number: 25198 | Start Date*: 2004-10-19 | |||||||||||
Sponsor Name:Serono International SA | |||||||||||||
Full Title: A phase IIIB/IV, open label study to assess the efficacy and safety of a pre-defined, fixed dose of Gonal-f® (Filled-by-Mass in a Prefilled Pen) based on subject baseline characteristics, for ovari... | |||||||||||||
Medical condition: Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) AT (Completed) GB (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
